High PD-L1 expression has been found in NPM1mut-AML (mainly in the leukemic progenitor cells; CD34+, CD38−) [67], with activity seen with nivolumab in in vitro studies [68]. This evidence concerns the gene CD34 and acute myeloid leukemia.